Thursday, September 07, 2017 2:36:14 PM
Not saying you're to blame for others losing. You're right, everyone makes their own decision. My point was that if you were incorrect about the plan the last time, at least hold open the possibility that you're mistaken again this time.
"Wouldn't you agree that would ONLY occur if there are no potential companies willing to buy them out or take them over?" No, I wouldn't agree. The business judgement rule gives a lot of flexibility to a CEO.
I'm sure there were companies willing to buy out RadioShack, or Blockbuster.
If I came in and offered $100 for the goodwill of the brand, would that have been an offer that management HAD to accept? Of course not.
Here's what Dr. Simpson would say:
On August 1, 2017 I received an offer to buy Delcath and all of its assets for $100M.
I decided that the better course of action would be to keep the company intact and move forward with plans to monetize after FDA approval. So, I instructed my attorneys to draft another reverse split prospectus, and solicit the shareholders for approval.
If there's no approval, and the offer is still on the table, would she be legally required to take it? I still don't think so. Again, what if the offer were dropped to $1,000,000? $100,000? $1?
Just because there's an offer and no other alternatives doesn't mean she has to take it. The alternative she does have is to go into bankruptcy protection and try to restructure.
It's the same principle as if I owed you $100,000 and my house is worth $1,000,000. If someone comes along and offers me $100,001, do I have to sell? No. I can file for bankruptcy protection, and try to work out a payment plan with you -- or use the protection of the court to solicit more serious offers that would compensate you without destroying me.
"Wouldn't you agree that would ONLY occur if there are no potential companies willing to buy them out or take them over?" No, I wouldn't agree. The business judgement rule gives a lot of flexibility to a CEO.
I'm sure there were companies willing to buy out RadioShack, or Blockbuster.
If I came in and offered $100 for the goodwill of the brand, would that have been an offer that management HAD to accept? Of course not.
Here's what Dr. Simpson would say:
On August 1, 2017 I received an offer to buy Delcath and all of its assets for $100M.
I decided that the better course of action would be to keep the company intact and move forward with plans to monetize after FDA approval. So, I instructed my attorneys to draft another reverse split prospectus, and solicit the shareholders for approval.
If there's no approval, and the offer is still on the table, would she be legally required to take it? I still don't think so. Again, what if the offer were dropped to $1,000,000? $100,000? $1?
Just because there's an offer and no other alternatives doesn't mean she has to take it. The alternative she does have is to go into bankruptcy protection and try to restructure.
It's the same principle as if I owed you $100,000 and my house is worth $1,000,000. If someone comes along and offers me $100,001, do I have to sell? No. I can file for bankruptcy protection, and try to work out a payment plan with you -- or use the protection of the court to solicit more serious offers that would compensate you without destroying me.
Recent DCTH News
- Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/15/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:47:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 09:45:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 12:23:52 PM
- Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference • Business Wire • 05/12/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 01:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 12:12:12 PM
- Delcath Systems Reports First Quarter 2026 Results and Business Highlights • Business Wire • 05/07/2026 12:00:00 PM
- Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 • Business Wire • 05/07/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:24 PM
- Delcath Systems to Host First Quarter 2026 Earnings Call • Business Wire • 04/23/2026 12:30:00 PM
- Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma • Business Wire • 04/06/2026 12:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 12:56:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 12:55:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 12:52:52 PM
- Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting • Business Wire • 04/01/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:22:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:48:16 PM
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology • Business Wire • 03/03/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 02:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:06:06 PM
